ERs and PRs are both predictive and prognostic factors and play a crucial role in the treatment of patients with breast cancer.12,13 On the basis of the current study, invasive lobular carcinoma had the highest frequency of ER expression, followed by noninvasive tumors. This evidence concerns the gene ESR1 and breast carcinoma.